Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines
The Long Run with Luke Timmerman - Un pódcast de Timmerman Report
Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.
